Artificial Intelligence

As global tech leaders convene, Hong Kong aims to cement its role as a digital super-connector amid rising debates on AI governance and cross-border data.

With a massive $750M boost to its share buyback, Nutanix underscores its financial strength and bets on its future in hybrid multicloud and enterprise AI.

The revolving sushi chain posts strong sales and narrows losses, proving its automation and expansion strategy is paying off despite economic pressures.

Vancouver's SalesCloser Technologies begins trading on the TSXV. Can its autonomous AI agents revolutionize the multi-billion dollar sales industry?

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

Otis College's 2026 report, featuring Snap CEO Evan Spiegel, will dissect AI's impact on California's creative jobs, innovation, and policy.

A small environmental firm unveils a plan to upend global markets with a fraud-proof 'Physical Truth Infrastructure.' But can it deliver on its promises?

A new certification for AI-guided cardiac ultrasound seeks to solve the training and trust gap, making crucial heart scans more accessible for frontline providers.

From knitting injuries to problems with in-laws, medical codes are a costly mess. AI is now untangling the $36 billion problem, one bizarre diagnosis at a time.

HCM giant Paylocity buys AI startup Grayscale, signaling a major push to automate high-volume hiring. But can it solve the efficiency puzzle without bias?

Brazil launches Fair Play, an AI prosecutor to identify online racism. It promises access to justice but faces scrutiny over ethics and accuracy.

A new survey reveals a paradox: while most Americans use online health tools, few trust them, highlighting the crucial role of human healthcare providers.

US firm SunHydrogen opens a Japan office led by a top researcher, aiming to scale its solar hydrogen tech in one of the world's leading clean energy markets.

A new holding company from Rise8's founder offers an alternative to VC, aiming to scale mission-critical software without sacrificing founder autonomy.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.

Cybersecurity firm Minimus appoints elite tech lawyer Yael Nardi as CBO, signaling a radical new "operational powerhouse" strategy to dominate the market.

Ardian sells specialty contractor Acousti to Gamut Capital, a deal highlighting how AI and strategy can drive value even in a tough exit environment.